Macropinocytosis of extracellular glutathione ameliorates tumor necrosis factor α release in activated macrophages

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Gould, Neal S ^a,b   Min, Elysia ^a   Day, Brian J ^a,b,c  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; CIGARETTE SMOKE; CYTOCHALASIN D; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; FLUORESCENT DYE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; EXTRACELLULAR SPACE; IMMUNOMODULATION; INFLAMMATION; LUNG FLUID; LUNG LAVAGE; MACROPHAGE ACTIVATION; MACROPINOCYTOSIS; MALE; MOUSE; NONHUMAN; PINOCYTOSIS; PNEUMONIA; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECT; EXTRACELLULAR FLUID; INTRACELLULAR SPACE; LUNG ALVEOLUS MACROPHAGE; METABOLISM; SECRETION; SMOKING;

ANIMALIA;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; EXTRACELLULAR FLUID; EXTRACELLULAR SPACE; FLUORESCENT DYES; GLUTATHIONE; INFLAMMATION MEDIATORS; INTRACELLULAR SPACE; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; PINOCYTOSIS; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053448632     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025704     Document Type: Article

References (46)

1. Sixt SU, Peters J, (2010) Extracellular alveolar proteasome: possible role in lung injury and repair. Proc Am Thorac Soc 7: 91-96.
2. Ng AW, Bidani A, Heming TA, (2004) Innate host defense of the lung: effects of lung-lining fluid pH. Lung 182: 297-317.
3. Ciencewicki J, Trivedi S, Kleeberger SR, (2008) Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol 122: 456-468 quiz 469-470.
4. Kelly FJ, Cotgrove M, Mudway IS, (1996) Respiratory tract lining fluid antioxidants: the first line of defence against gaseous pollutants. Cent Eur J Public Health 4 (Suppl): 11-14.
5. Gould NS, Day BJ, (2011) Targeting maladaptive glutathione responses in lung disease. Biochem Pharmacol 81: 187-193.
6. Lensmar C, Elmberger G, Sandgren P, Skold CM, Eklund A, (1998) Leukocyte counts and macrophage phenotypes in induced sputum and bronchoalveolar lavage fluid from normal subjects. Eur Respir J 12: 595-600.
7. Cantin AM, Begin R, (1991) Glutathione and inflammatory disorders of the lung. Lung 169: 123-138.
8. Morris PE, Bernard GR, (1994) Significance of glutathione in lung disease and implications for therapy. Am J Med Sci 307: 119-127.
9. Teramoto S, Fukuchi Y, Uejima Y, Teramoto K, Ito H, et al. (1994) Age-related changes in the antioxidant screen of the distal lung in mice. Lung 172: 223-230.
10. Ghezzi P, (2011) Role of glutathione in immunity and inflammation in the lung. Int J Gen Med 4: 105-113.
11. Allen TC, (2010) Pathology of small airways disease. Arch Pathol Lab Med 134: 702-718.
12. Willemse BW, ten Hacken NH, Rutgers B, Lesman-Leegte IG, Timens W, et al. (2004) Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD. Eur Respir J 24: 391-396.
13. Churg A, Wang RD, Tai H, Wang X, Xie C, et al. (2004) Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 170: 492-498.
14. Gould NS, Min E, Gauthier S, Chu HW, Martin R, et al. (2010) Aging Adversely Affects the Cigarette Smoke Induced Glutathione Adaptive Response in the Lung. Am J Respir Crit Care Med.
15. Barnes PJ, (2004) Alveolar macrophages as orchestrators of COPD. COPD 1: 59-70.
16. Birrell MA, Wong S, Catley MC, Belvisi MG, (2008) Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol 214: 27-37.
17. Kariya C, Chu HW, Huang J, Leitner H, Martin RJ, et al. (2008) Mycoplasma pneumoniae infection and environmental tobacco smoke inhibit lung glutathione adaptive responses and increase oxidative stress. Infect Immun 76: 4455-4462.
18. Day BJ, van Heeckeren AM, Min E, Velsor LW, (2004) Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection. Infect Immun 72: 2045-2051.
19. Haddad JJ, (2000) Glutathione depletion is associated with augmenting a proinflammatory signal: evidence for an antioxidant/pro-oxidant mechanism regulating cytokines in the alveolar epithelium. Cytokines Cell Mol Ther 6: 177-187.
20. Seres T, Knickelbein RG, Warshaw JB, Johnston RB Jr, (2000) The phagocytosis-associated respiratory burst in human monocytes is associated with increased uptake of glutathione. J Immunol 165: 3333-3340.
21. Iyer SS, Ramirez AM, Ritzenthaler JD, Torres-Gonzalez E, Roser-Page S, et al. (2009) Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol 296: L37-45.
22. Kinnula VL, Soini Y, Kvist-Makela K, Savolainen ER, Koistinen P, (2002) Antioxidant defense mechanisms in human neutrophils. Antioxid Redox Signal 4: 27-34.
23. Pietarinen-Runtti P, Lakari E, Raivio KO, Kinnula VL, (2000) Expression of antioxidant enzymes in human inflammatory cells. Am J Physiol Cell Physiol 278: C118-125.
24. Barnes PJ, (2004) Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 56: 515-548.
25. Tetley TD, (2005) Inflammatory cells and chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 4: 607-618.
26. Ulrich M, Worlitzsch D, Viglio S, Siegmann N, Iadarola P, et al. (2010) Alveolar inflammation in cystic fibrosis. J Cyst Fibros 9: 217-227.
27. Gosset P, Wallaert B, Tonnel AB, Fourneau C, (1999) Thiol regulation of the production of TNF-alpha, IL-6 and IL-8 by human alveolar macrophages. Eur Respir J 14: 98-105.
28. Aderem A, Underhill DM, (1999) Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17: 593-623.
29. Swanson JA, Watts C, (1995) Macropinocytosis. Trends Cell Biol 5: 424-428.
30. Koivusalo M, Welch C, Hayashi H, Scott CC, Kim M, et al. (2010) Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol 188: 547-563.
31. Haddad JJ, (2001) L-Buthionine-(S,R)-sulfoximine, an irreversible inhibitor of gamma-glutamylcysteine synthetase, augments LPS-mediated pro-inflammatory cytokine biosynthesis: evidence for the implication of an IkappaB-alpha/NF-kappaB insensitive pathway. Eur Cytokine Netw 12: 614-624.
32. Alam K, Ghousunnissa S, Nair S, Valluri VL, Mukhopadhyay S, (2010) Glutathione-redox balance regulates c-rel-driven IL-12 production in macrophages: possible implications in antituberculosis immunotherapy. J Immunol 184: 2918-2929.
33. Dobashi K, Aihara M, Araki T, Shimizu Y, Utsugi M, et al. (2001) Regulation of LPS induced IL-12 production by IFN-gamma and IL-4 through intracellular glutathione status in human alveolar macrophages. Clin Exp Immunol 124: 290-296.
34. Haddad JJ, (2002) The involvement of L-gamma-glutamyl-L-cysteinyl-glycine (glutathione/GSH) in the mechanism of redox signaling mediating MAPK(p38)-dependent regulation of pro-inflammatory cytokine production. Biochem Pharmacol 63: 305-320.
35. Hashimoto S, Gon Y, Matsumoto K, Takeshita I, MacHino T, et al. (2001) Intracellular glutathione regulates tumour necrosis factor-alpha-induced p38 MAP kinase activation and RANTES production by human bronchial epithelial cells. Clin Exp Allergy 31: 144-151.
36. Rahman I, Biswas SK, Jimenez LA, Torres M, Forman HJ, (2005) Glutathione, stress responses, and redox signaling in lung inflammation. Antioxid Redox Signal 7: 42-59.
37. Forman HJ, Torres M, (2002) Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 166: S4-8.
38. Eun JS, Suh YH, Kim DK, Jeon H, (2000) Regulation of cytokine production by exogenous nitric oxide in murine splenocyte and peritoneal macrophage. Arch Pharm Res 23: 531-534.
39. Dobrovolskaia MA, Vogel SN, (2002) Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 4: 903-914.
40. Brennan S, Sly PD, Gangell CL, Sturges N, Winfield K, et al. (2009) Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis. Eur Respir J 34: 655-661.
41. Bruscia EM, Zhang PX, Ferreira E, Caputo C, Emerson JW, et al. (2009) Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/- mice. Am J Respir Cell Mol Biol 40: 295-304.
42. Rottner M, Freyssinet JM, Martinez MC, (2009) Mechanisms of the noxious inflammatory cycle in cystic fibrosis. Respir Res 10: 23.
43. Griese M, Ramakers J, Krasselt A, Starosta V, Van Koningsbruggen S, et al. (2004) Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am J Respir Crit Care Med 169: 822-828.
44. Bishop C, Hudson VM, Hilton SC, Wilde C, (2005) A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis. Chest 127: 308-317.
45. Buhl R, Vogelmeier C, Critenden M, Hubbard RC, Hoyt RF Jr, et al. (1990) Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proc Natl Acad Sci U S A 87: 4063-4067.
46. Gould NS, Gauthier S, Kariya CT, Min E, Huang J, et al. (2010) Hypertonic saline increases lung epithelial lining fluid glutathione and thiocyanate: two protective CFTR-dependent thiols against oxidative injury. Respir Res 11: 119.